| What is RSS feed? | About Us |
 |
 Search Score: 6/10
Source: economictimes.indiatimes.com --- 26 days ago
An experimental drug from Swiss drugmaker Novartis AG has been granted priority review in the United States as a treatment for advanced kidney cancer. ... Source: www.moreover.com --- 27 days ago
LONDON, Sept 9 (Reuters) - Novartis AG's drug Galvus is better tolerated and as effective as commonly prescribed anti-diabetics known as thiazolidinediones (TZDs), when added to the older drug metformin, researchers said on Tuesday. ... Source: www.moreover.com --- 26 days ago
ZURICH, Sept 10 (Reuters) - Novartis said new research showed that its investigational Meningitis B vaccine may be the first to protect infants of six months and older against multiple strains of the potentially deadly bacteria. ... Source: www.moreover.com --- 3 days ago
Extract not available. ... Source: www.moreover.com --- 14 days ago
ZURICH (Reuters) - Sandoz, the generic drugs unit of Novartis, could lose World Health Organisation authorisation to sell some of its antibiotics due to problems at a South African plant, the Financial Times reported on Monday. ... Source: www.moreover.com --- 20 days ago
The FDA has granted priority review to Novartis kidney cancer treatment RAD001, an investigational drug studied in a Phase III trial for multiple tumor types. ... Source: www.marketwatch.com --- 14 days ago
BOSTON (MarketWatch) -- The World Health Organization has found one of Novartis AG's generic drugs manufacturing plants out of compliance, the Financial Times reported Monday. According to the report, WHO has determined that a South African plant used to make antibiotics for Novartis' generics unit Sandoz has been found deficient on 41 in complying with the agency's "good manufacturing practises" code. Until the situation is rectified, Novartis runs the risk of losing WHO's authorization to sell antibiotics manufactured at the plant, which is located in Kempton Park, Gauteng. The newspaper says Novartis plans to make the needed changes by the first quarter 2009. ... Source: www.prnewswire.com --- 3 days ago
... Source: www.bostonherald.com --- 23 days ago
The global health-care company Novartis AG has increased its presence in Cambridge. Yesterday, Novartis CEO Joerg Reinhardt and other top executives joined the Swiss... ... Source: www.bostonherald.com --- 21 days ago
Novartis AG just opened a vaccine research lab in Cambridge, and Genzyme Corp. will put its Framingham science center on display for the first time next week. Even with... ... Source: clientportal.ibb.ubs.com --- 24 days ago
This document is related to the following: Regions Switzerland Europe Including UK Europe Ex. UK Global UBSW EMEA Sectors Swiss Pharmaceuticals European Pharmaceuticals European Ex. UK Pharmaceuticals Global Pharmaceuticals Swiss Healthcare European Healthcare European Ex. UK Healthcare Global Healthcare Companies ROG.VX Roche NOVN.VX Novartis Subjects Company Update Morning Note ... Source: www.moreover.com --- 27 days ago
Reuters Sep 9 2008 6:09AM GMT ... Source: www.moreover.com --- 25 days ago
MarketWatch Sep 11 2008 9:08AM GMT ... Source: www.cen-chemjobs.org --- 3 days ago
Job DescriptionVertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. Th ... Source: clientportal.ibb.ubs.com --- 13 days ago
This document is related to the following: Regions Switzerland Europe Including UK Europe Ex. UK Global UBSW EMEA Sectors Swiss Pharmaceuticals European Pharmaceuticals European Ex. UK Pharmaceuticals Global Pharmaceuticals Swiss Healthcare European Healthcare European Ex. UK Healthcare Global Healthcare Companies ROG.VX Roche NOVN.VX Novartis Subjects Company Update Morning Note ... Source: www.moreover.com --- 32 days ago
Datamonitor Sep 4 2008 2:58AM GMT ... Source: feeds.business-standard.com --- 18 days ago
Novartis India, the Indian arm of Swiss drug major Novartis, has launched a nationwide novel drug marketing initiative named Arogya Parivar, specifically targeting healthcare needs of villagers. ... Source: www.postchronicle.com --- 35 days ago
More than 2 percent of patients undergoing non-cardiac vascular surgery -- surgery to arteries and veins -- die from heart attacks and other cardiovascular problems.... ... Source: www.gotapex.com --- 21 days ago
FREE BetterBoneHealth Program Sign-up (Novartis) BetterBoneHealth is an educational resource that strives to provide you with valuable information about cancer in your bones (bone metastases), how cancer may spread to the bones, and ways to effectively protect against and reduce the complications... ... Find more results for Novartis on RSSMicro.com |
Copyright © 2008 RSSMicro.com
CNBC's Simon Hobbs speaks to Daniel Vasella, chairman and CEO of Novartis, about how he has remained one of Europe's most influential and highly paid leaders for more than a decade. ...